logo

APUS

Apimeds·AMEX
--
--(--)
--
--(--)
5.28 / 10
Netural

Assessment shows fair fundamentals at 5.3/10. Constructive elements: Interest coverage ratio (EBIT / Interest expense) (%) and Revenue-MV, though challenges appear in Days sales outstanding. Investment case: moderate.

Fundamental(5.28)SentimentTechnical

Analysis Checks(9/10)

Revenue-MV
Value-0.26
Score3/3
Weight17.30%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.48%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-1.90%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight13.79%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight13.81%
1M Return8.45%
PB-ROE
Value1.39
Score2/3
Weight17.20%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.38%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.57%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight25.57%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight13.56%
1M Return8.41%
Is APUS fundamentally strong?
  • APUS scores 5.28/10 on fundamentals and holds a Fair valuation at present. Backed by its -142.47% ROE, 0.00% net margin, -5.49 P/E ratio, 2.50 P/B ratio, and -75.86% earnings growth, these metrics solidify its Netural investment rating.